Bio-Path Holdings Statistics
Total Valuation
BPTH has a market cap or net worth of $5.45 million. The enterprise value is $5.28 million.
Important Dates
The last earnings date was Friday, November 15, 2024, before market open.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BPTH has 4.31 million shares outstanding. The number of shares has increased by 251.10% in one year.
| Current Share Class | 4.31M |
| Shares Outstanding | 4.31M |
| Shares Change (YoY) | +251.10% |
| Shares Change (QoQ) | +87.16% |
| Owned by Insiders (%) | 9.08% |
| Owned by Institutions (%) | 1.37% |
| Float | 3.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.86
| Current Ratio | 0.86 |
| Quick Ratio | 0.17 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1,159.74% and return on invested capital (ROIC) is -782.83%.
| Return on Equity (ROE) | -1,159.74% |
| Return on Assets (ROA) | -194.09% |
| Return on Capital (ROIC) | -782.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.05M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.56% in the last 52 weeks. The beta is 0.22, so BPTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -87.56% |
| 50-Day Moving Average | 0.90 |
| 200-Day Moving Average | 1.83 |
| Relative Strength Index (RSI) | 59.70 |
| Average Volume (20 Days) | 6,141,343 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.40M |
| Pretax Income | -13.96M |
| Net Income | -10.51M |
| EBITDA | -12.35M |
| EBIT | -12.40M |
| Earnings Per Share (EPS) | -$7.13 |
Full Income StatementBalance Sheet
The company has $562,000 in cash and $26,000 in debt, giving a net cash position of $536,000 or $0.12 per share.
| Cash & Cash Equivalents | 562,000 |
| Total Debt | 26,000 |
| Net Cash | 536,000 |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | -712,000 |
| Book Value Per Share | -0.19 |
| Working Capital | -476,000 |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.51M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.51M |
| FCF Per Share | -$2.21 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BPTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -251.10% |
| Shareholder Yield | -251.10% |
| Earnings Yield | -180.81% |
| FCF Yield | -163.53% |
Analyst Forecast
The average price target for BPTH is $30.00, which is 2,268.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.00 |
| Price Target Difference | 2,268.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on February 23, 2024. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Feb 23, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |